HomeAI · summaries
Storia in 3 fonti
US tariff threat drags Nifty Pharma 1.4% lower; Lupin, Auropharma lead decline
US tariff threats lead to a 1.4% drop in Nifty Pharma, with Lupin and Auropharma experiencing significant declines.
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
economictimes.indiatimes.com
Sun Pharma, Cipla, other pharma stocks in focus as Trump unveils 100%, 200% tariffs on generic drugs from 2028
Indian pharma stocks are likely to remain in focus after US President Donald Trump announced a phased tariff plan for generic medicines, offering a two-year tariff exemption…
- ·
thehindubusinessline.com
Nifty opens lower; pharma stocks bleed, auto sector shines
The Sensex declined more than 400 points and the Nifty slipped below 24,100 in early trade amid higher crude oil prices and geopolitical concerns
- ·
timesofindia.indiatimes.com
Pharma stocks bleed after Trump announces up to 200% tariff on generic drugs; Aurobindo, Sun Pharma & Cipla slide over 3%
Pharmaceutical stocks came under pressure on Wednesday after US President Donald Trump unveiled a phased tariff plan for imported generic medicines, raising concerns over the…
- ·
Pharma stocks decline; Aurobindo Pharma down over 4%
Pharma stocks fall as Aurobindo Pharma drops over 4% following Trump's tariff announcement on imported generic medicines.
- ·
US tariff threat drags Nifty Pharma 1.4% lower; Lupin, Auropharma lead decline
US tariff threats lead to a 1.4% drop in Nifty Pharma, with Lupin and Auropharma experiencing significant declines.